South African investors have a limited pool of stocks to invest in when it comes to the healthcare sector but the US has no such constraints and the team from the Motley Fool unpack this sector:

Special guest Simon Erickson dives into this burgeoning field with host Shannon Jones, discussing:

– The role of genomics, and how its changed how doctors look at patients.

– How analyzing the genome can lead to better outcomes in a variety of fields, including oncology (the study of cancer) — specifically making huge strides in how doctors are able to detect cancer.

– The benefits of liquid biopsies and how it might help with the earlier detection of cancer.

– Why a gene sequencing company like Illumina (NASDAQ: ILMN), could be the company to watch in the space, and why investors should also keep an eye on: Roche (NASDAQOTH: RHHBY), Guardant Health (NASDAQ: GH):